Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Paterson

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|May 11, 2011
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patientsS M Garonzik, J Li, V Thamlikitkul, et al.
Transplantation|January 12, 1999
Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for managementC A Bonham, E A Dominguez, M B Fukui, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 14, 2014
Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in TurkeyP Zarakolu, K M Day, H E Sidjabat, et al.
Lancet (London, England)|January 11, 1997
Fatal encephalitis due to novel paramyxovirus transmitted from horsesJ D O'Sullivan, A M Allworth, D L Paterson, et al.
Internal Medicine Journal|November 29, 2012
Vancomycin therapeutics and monitoring: a contemporary approachM L Avent, V L Vaska, B A Rogers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2016
Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012-2014: prospective, repeated cross-sectional studyL Furuya-Kanamori, A C A Clements, N F Foster, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2009
Voriconazole pharmacokinetics in liver transplant recipientsH J Johnson, Kelong Han, B Capitano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 26, 2006
Voriconazole prophylaxis in lung transplant recipientsS Husain, D L Paterson, S Studer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2009
Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, SpainY Doi, D L Paterson, P Egea, et al.
Journal of Clinical Microbiology|May 29, 2001
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratoryD L Paterson, W C Ko, A Von Gottberg, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|May 11, 2011
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patientsS M Garonzik, J Li, V Thamlikitkul, et al.
Transplantation|January 12, 1999
Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for managementC A Bonham, E A Dominguez, M B Fukui, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 14, 2014
Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in TurkeyP Zarakolu, K M Day, H E Sidjabat, et al.
Lancet (London, England)|January 11, 1997
Fatal encephalitis due to novel paramyxovirus transmitted from horsesJ D O'Sullivan, A M Allworth, D L Paterson, et al.
Internal Medicine Journal|November 29, 2012
Vancomycin therapeutics and monitoring: a contemporary approachM L Avent, V L Vaska, B A Rogers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2016
Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012-2014: prospective, repeated cross-sectional studyL Furuya-Kanamori, A C A Clements, N F Foster, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2009
Voriconazole pharmacokinetics in liver transplant recipientsH J Johnson, Kelong Han, B Capitano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 26, 2006
Voriconazole prophylaxis in lung transplant recipientsS Husain, D L Paterson, S Studer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2009
Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, SpainY Doi, D L Paterson, P Egea, et al.
Journal of Clinical Microbiology|May 29, 2001
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratoryD L Paterson, W C Ko, A Von Gottberg, et al.
Pageof 12